Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus

Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

Correspondence to Natalie E. Lee, MSci, MBChB, Dr, Clinical Infection Research Group, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh EH4 2XU, UK. E-mail: [email protected]

留言 (0)

沒有登入
gif